{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T15:14:14Z","timestamp":1795014854683,"version":"4.9.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,30]],"date-time":"2023-11-30T00:00:00Z","timestamp":1701302400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,30]],"date-time":"2023-11-30T00:00:00Z","timestamp":1701302400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100007637","name":"Departamento Administrativo de Ciencia, Tecnolog\u00eda e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["PhD call 860"],"award-info":[{"award-number":["PhD call 860"]}],"id":[{"id":"10.13039\/100007637","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","award":["531002021"],"award-info":[{"award-number":["531002021"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Regular participation in cervical cancer screening is critical to reducing mortality. Although certain sociodemographic factors are known to be associated with one-time participation in screening, little is known about other factors that could be related to regular participation. Therefore, this study evaluated the association between health-related behavioral factors and regular participation in cervical cancer screening.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The Lifelines population-based cohort was linked to data for cervical cancer screening from the Dutch Nationwide Pathology Databank. We included women eligible for all four screening rounds between 2000 and 2019, classifying them as regular (4 attendances), irregular (1\u20133 attendances), and never participants. Multinomial logistic regression was performed to evaluate the association between behavioral factors and participation regularity, with adjustment made for sociodemographic factors.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Of the 48,325 included women, 55.9%, 35.1%, and 9% were regular, irregular, and never screening participants. After adjustment for sociodemographic factors, the likelihood of irregular or never screening participation was increased by smoking, obesity, marginal or inadequate sleep duration, alcohol consumption and low physical activity, while it was decreased by hormonal contraception use.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>An association exists between unhealthy behavioral factors and never or irregular participation in cervical cancer screening.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12889-023-17293-0","type":"journal-article","created":{"date-parts":[[2023,11,30]],"date-time":"2023-11-30T11:02:29Z","timestamp":1701342149000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Impact of health-related behavioral factors on participation in a cervical cancer screening program: the lifelines population-based cohort"],"prefix":"10.1186","volume":"23","author":[{"given":"Kelly M.","family":"Casta\u00f1eda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grigory","family":"Sidorenkov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marian J. E.","family":"Mourits","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bert","family":"van der Vegt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert G.","family":"Siebers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin M.","family":"Vermeulen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ed","family":"Schuuring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. Bea A.","family":"Wisman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geertruida H.","family":"de Bock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,30]]},"reference":[{"key":"17293_CR1","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.ejca.2019.12.013","volume":"127","author":"EEL Jansen","year":"2020","unstructured":"Jansen EEL, Zielonke N, Gini A, Anttila A, Segnan N, Vok\u00f3 Z, et al. Effect of organised cervical cancer screening on cervical cancer mortality in Europe: a systematic review. Eur J Cancer. 2020;127:207\u201323.","journal-title":"Eur J Cancer"},{"key":"17293_CR2","unstructured":"Global Cancer Observatory. Estimated age-standardized incidence and mortality rates (World) in 2020, all cancers, both sexes, all ages, Western Europe. 2022. https:\/\/gco.iarc.fr\/today\/online-analysis-multi-bars?v=2020&mode=population&mode_population=countries&population=900&populations=900&key=asr&sex=0&cancer=39&type=0&statistic=5&prevalence=0&population_group=17&ages_group%5B%5D=0&ages_group%5B%5D=17&nb_items=10&group_cancer=1&include_nmsc=0&include_nmsc_other=1&type_multiple=%257B%2522inc%2522%253Atrue%252C%2522mort%2522%253Atrue%252C%2522prev%2522%253Afalse%257D&orientation=horizontal&type_sort=0&type_nb_items=%257B%2522top%2522%253Atrue%252C%2522bottom%2522%253Afalse%257D&population_group_list=40,56,250,276,442,756,528&population_group_globocan_id=926. Accessed 29 Jun 2022."},{"key":"17293_CR3","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1002\/ijc.22114","volume":"119","author":"AB Bos","year":"2006","unstructured":"Bos AB, Rebolj M, Habbema JDF, Van Ballegooijen M. Nonattendance is still the main limitation for the effectiveness of screening for cervical cancer in the Netherlands. Int J Cancer. 2006;119:2372\u20135.","journal-title":"Int J Cancer"},{"key":"17293_CR4","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1016\/j.ejca.2015.03.008","volume":"51","author":"KM Elfstr\u00f6m","year":"2015","unstructured":"Elfstr\u00f6m KM, Arnheim-Dahlstr\u00f6m L, Von Karsa L, Dillner J. Cervical cancer screening in Europe: Quality assurance and organisation of programmes. Eur J Cancer. 2015;51:950\u201368.","journal-title":"Eur J Cancer"},{"key":"17293_CR5","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.cmi.2019.09.006","volume":"26","author":"PJ Maver","year":"2020","unstructured":"Maver PJ, Poljak M. Primary HPV-based cervical cancer screening in Europe: implementation status, challenges, and future plans. Clin Microbiol Infect. 2020;26:579\u201383.","journal-title":"Clin Microbiol Infect"},{"key":"17293_CR6","doi-asserted-by":"publisher","first-page":"101328","DOI":"10.1016\/j.pmedr.2021.101328","volume":"22","author":"CA Aitken","year":"2021","unstructured":"Aitken CA, Kaljouw S, Siebers AG, Bron M, Morssink A, van Kemenade FJ, et al. Investigating the decrease in participation in the Dutch cervical cancer screening programme: the role of personal and organisational characteristics. Prev Med Rep. 2021;22.","journal-title":"Prev Med Rep"},{"key":"17293_CR7","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1093\/eurpub\/ckl082","volume":"17","author":"MAJB Tacken","year":"2007","unstructured":"Tacken MAJB, Braspenning JCC, Hermens RPMG, Spreeuwenberg PMM, Van Den Hoogen HJM, De Bakker DH, et al. Uptake of cervical cancer screening in The Netherlands is mainly influenced by women\u2019s beliefs about the screening and by the inviting organization. Eur J Public Health. 2007;17:178\u201385.","journal-title":"Eur J Public Health"},{"key":"17293_CR8","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.ypmed.2018.02.035","volume":"111","author":"E Harder","year":"2018","unstructured":"Harder E, Juul KE, Jensen SM, Thomsen LT, Frederiksen K, Kjaer SK. Factors associated with non-participation in cervical cancer screening \u2013 A nationwide study of nearly half a million women in Denmark. Prev Med (Baltim). 2018;111:94\u2013100.","journal-title":"Prev Med (Baltim)"},{"key":"17293_CR9","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1097\/CEJ.0000000000000088","volume":"24","author":"I Ricardo-Rodrigues","year":"2015","unstructured":"Ricardo-Rodrigues I, Jim\u00e9nez-Garc\u00eda R, Hern\u00e1ndez-Barrera V, Carrasco-Garrido P, Jim\u00e9nez-Trujillo I, L\u00f3pez-De-Andr\u00e9s A. Adherence to and predictors of participation in colorectal cancer screening with faecal occult blood testing in Spain, 2009\u20132011. Eur J Cancer Prev. 2015;24:305\u201312.","journal-title":"Eur J Cancer Prev"},{"key":"17293_CR10","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.1158\/1055-9965.EPI-10-0338","volume":"19","author":"M Caleffi","year":"2010","unstructured":"Caleffi M, Ribeiro RA, Bedin AJ, Viegas-Butzke JMP, Baldisserotto FDG, Skonieski GP, et al. Adherence to a breast cancer screening program and its predictors in underserved women in southern Brazil. Cancer Epidemiol Biomarkers Prev. 2010;19:2673\u20139.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"17293_CR11","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.pec.2013.06.029","volume":"93","author":"K Bronner","year":"2013","unstructured":"Bronner K, Mesters I, Weiss-Meilik A, Geva R, Rozner G, Strul H, et al. Determinants of adherence to screening by colonoscopy in individuals with a family history of colorectal cancer. Patient Educ Couns. 2013;93:272\u201381.","journal-title":"Patient Educ Couns"},{"key":"17293_CR12","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1186\/1471-2458-11-264","volume":"11","author":"BT Hansen","year":"2011","unstructured":"Hansen BT, Hukkelberg SS, Haldorsen T, Eriksen T, Skare GB, Nyg\u00e5rd M. Factors associated with non-attendance, opportunistic attendance and reminded attendance to cervical screening in an organized screening program: a cross-sectional study of 12,058 Norwegian women. BMC Public Health. 2011;11:264.","journal-title":"BMC Public Health"},{"key":"17293_CR13","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1097\/CEJ.0000000000000068","volume":"24","author":"P Barbadoro","year":"2015","unstructured":"Barbadoro P, Ricciardi A, Di Tondo E, Vallorani S, Mazzarini G, Prospero E. Utilization patterns of cervical cancer screening in Italy. Eur J Cancer Prev. 2015;24:135\u201340.","journal-title":"Eur J Cancer Prev"},{"key":"17293_CR14","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1016\/j.canep.2015.09.009","volume":"39","author":"A Richard","year":"2015","unstructured":"Richard A, Rohrmann S, Schmid SM, Tirri BF, Huang DJ, G\u00fcth U, et al. Lifestyle and health-related predictors of cervical cancer screening attendance in a Swiss population-based study. Cancer Epidemiol. 2015;39:870\u20136.","journal-title":"Cancer Epidemiol"},{"key":"17293_CR15","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1158\/1055-9965.EPI-18-0480","volume":"27","author":"E Harder","year":"2018","unstructured":"Harder E, Thomsen LT, Hertzum-Larsen R, Albieri V, Hessner MV, Juul KE, et al. Determinants for participation in human papillomavirus self-sampling among nonattenders to cervical cancer screening in Denmark. Cancer Epidemiol Biomark Prev. 2018;27:1342\u201351.","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"17293_CR16","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s10654-007-9204-4","volume":"23","author":"RP Stolk","year":"2008","unstructured":"Stolk RP, Rosmalen JG, Postma DS, de Boer RA, Navis G, Slaets JP, et al. Universal risk factors for multifactorial diseases: LifeLines: a three-generation population-based study. Eur J Epidemiol. 2008;23:67\u201374.","journal-title":"Eur J Epidemiol"},{"key":"17293_CR17","doi-asserted-by":"crossref","unstructured":"Scholtens S, Smidt N, Swertz MA, Jl Bakker S, Dotinga A, Vonk JM, et al. Cohort Profile: LifeLines, a three-generation cohort study and biobank. Int J Epidemiol. 2015;:1172\u201380.","DOI":"10.1093\/ije\/dyu229"},{"key":"17293_CR18","doi-asserted-by":"publisher","first-page":"e295","DOI":"10.1093\/ije\/dyab257","volume":"51","author":"A Sijtsma","year":"2022","unstructured":"Sijtsma A, Rienks J, van der Harst P, Navis G, Rosmalen JGM, Dotinga A. Cohort Profile Update: Lifelines, a three-generation cohort study and biobank. Int J Epidemiol. 2022;51:e295\u2013302.","journal-title":"Int J Epidemiol"},{"key":"17293_CR19","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1186\/s12916-019-1460-0","volume":"17","author":"CA Aitken","year":"2019","unstructured":"Aitken CA, van Agt HME, Siebers AG, van Kemenade FJ, Niesters HGM, Melchers WJG, et al. Introduction of primary screening using high-risk HPV DNA detection in the Dutch cervical cancer screening programme: a population-based cohort study. BMC Med. 2019;17:228.","journal-title":"BMC Med"},{"key":"17293_CR20","unstructured":"National Institute for Public Health and the Environment. Framework for the execution of the Dutch cervical cancer screening programme. 2021. https:\/\/www.rivm.nl\/documenten\/framework-for-execution-of-cervical-cancer-population-screening. Accessed 20 Jan 2022."},{"key":"17293_CR21","unstructured":"Aitken CA. Implementation of Primary hrHPV-based cervical cancer screening in the Netherlands. Rotterdam: Doctoral thesis, Erasmus University Rotterdam; 2021."},{"key":"17293_CR22","doi-asserted-by":"publisher","unstructured":"Casta\u00f1eda KM, Sidorenkov GA, de Waard J, Greuter MJW, van der Vegt B, de Kok IMCM, et al. The effect of extended participation windows on attendance at cervical cancer screening. Prev Med Rep. 2023;32.\u00a0https:\/\/doi.org\/10.1016\/j.pmedr.2023.102166.","DOI":"10.1016\/j.pmedr.2023.102166"},{"key":"17293_CR23","doi-asserted-by":"publisher","unstructured":"Cort\u00e9s-Ib\u00e1\u00f1ez FO, Jaramillo-Calle DA, Vinke PC, Byambasukh O, Corpeleijn E, Sijtsma A, et al. Comparison of health behaviours between cancer survivors and the general population: a cross-sectional analysis of the Lifelines cohort. https:\/\/doi.org\/10.1007\/s11764-020-00854-2.","DOI":"10.1007\/s11764-020-00854-2"},{"key":"17293_CR24","unstructured":"Alcohol - Achtergronddocument bij Richtlijnen goede voeding 2015 | Advies | Gezondheidsraad. https:\/\/www.gezondheidsraad.nl\/documenten\/adviezen\/2015\/11\/04\/alcohol-achtergronddocument-bij-richtlijnen-goede-voeding-2015. Accessed 4 Nov 2022."},{"key":"17293_CR25","unstructured":"Calculate Your BMI - Standard BMI Calculator. https:\/\/www.nhlbi.nih.gov\/health\/educational\/lose_wt\/BMI\/bmicalc.htm. Accessed 16 Aug 2022."},{"key":"17293_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12966-018-0661-9","volume":"15","author":"RM Weggemans","year":"2018","unstructured":"Weggemans RM, Backx FJG, Borghouts L, Chinapaw M, Hopman MTE, Koster A, et al. The 2017 Dutch physical activity guidelines. Int J Behav Nutr Phys Act. 2018;15:1\u201312.","journal-title":"Int J Behav Nutr Phys Act"},{"key":"17293_CR27","unstructured":"Monitoring en evaluatie | RIVM. https:\/\/www.rivm.nl\/bevolkingsonderzoek-baarmoederhalskanker\/professionals\/monitoring-en-evaluatie. Accessed 4 Nov 2022."},{"key":"17293_CR28","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1111\/1471-0528.16400","volume":"128","author":"EEL Jansen","year":"2021","unstructured":"Jansen EEL, Naber SK, Aitken CA, de Koning HJ, van Ballegooijen M, de Kok IMCM. Cost-effectiveness of HPV-based cervical screening based on first year results in the Netherlands: a modelling study. BJOG. 2021;128:573\u201382.","journal-title":"BJOG"},{"key":"17293_CR29","doi-asserted-by":"publisher","first-page":"321","DOI":"10.3322\/caac.21628","volume":"70","author":"ETH Fontham","year":"2020","unstructured":"Fontham ETH, Wolf AMD, Church TR, Etzioni R, Flowers CR, Herzig A, et al. Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society. CA Cancer J Clin. 2020;70:321\u201346.","journal-title":"CA Cancer J Clin"},{"key":"17293_CR30","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1177\/0969141316630766","volume":"23","author":"J Chubak","year":"2016","unstructured":"Chubak J, Hubbard R. Defining and measuring adherence to cancer screening. J Med Screen. 2016;23:179.","journal-title":"J Med Screen"},{"key":"17293_CR31","doi-asserted-by":"crossref","unstructured":"Hansen BT, Hukkelberg SS, Haldorsen T, Eriksen T, Nyg\u00e5rd M. Factors associated with non-attendance, opportunistic attendance and reminded attendance to cervical screening in an organized screening program: a cross-sectional study of 12,058 Norwegian women. 2011.","DOI":"10.1186\/1471-2458-11-264"},{"key":"17293_CR32","doi-asserted-by":"publisher","unstructured":"Lee I-C, Chang C-S, Du P-L. Do healthier lifestyles lead to less utilization of healthcare resources? https:\/\/doi.org\/10.1186\/s12913-017-2185-4.","DOI":"10.1186\/s12913-017-2185-4"},{"key":"17293_CR33","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1002\/cncr.23408","volume":"112","author":"SS Cohen","year":"2008","unstructured":"Cohen SS, Palmieri RT, Nyante SJ, Koralek DO, Kim S, Bradshaw P, et al. A review: Obesity and screening for breast, cervical, and colorectal cancer in women. Cancer. 2008;112:1892\u2013904.","journal-title":"Cancer"},{"key":"17293_CR34","unstructured":"Centraal Bureau voor de Statistiek. Dutch drink one unit of alcohol a day on average. https:\/\/www.cbs.nl\/en-gb\/news\/2010\/18\/dutch-drink-one-unit-of-alcohol-a-day-on-average. Accessed 11 Nov 2022."},{"key":"17293_CR35","doi-asserted-by":"publisher","first-page":"9","DOI":"10.5665\/sleep.3298","volume":"37","author":"DJ Buysse","year":"2014","unstructured":"Buysse DJ. Sleep health: Can we define it? Does it matter? Sleep. 2014;37:9\u201317.","journal-title":"Sleep"},{"key":"17293_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/J.SLEH.2022.08.010","author":"C Omichi","year":"2022","unstructured":"Omichi C, Koyama T, Kadotani H, Ozaki E, Tomida S, Yoshida T, et al. Irregular sleep and all-cause mortality: a large prospective cohort study. Sleep Health. 2022. https:\/\/doi.org\/10.1016\/J.SLEH.2022.08.010.","journal-title":"Sleep Health"},{"key":"17293_CR37","doi-asserted-by":"crossref","unstructured":"Stevens C, Vrinten C, Smith SG, Waller J, Beeken RJ. Determinants of willingness to receive healthy lifestyle advice in the context of cancer screening. Br J Cancer. 2018;119:251\u20137.","DOI":"10.1038\/s41416-018-0160-4"},{"key":"17293_CR38","doi-asserted-by":"crossref","unstructured":"Riggi E, Baccini M, Camussi E, Gallo F, Anatrone C, Pezzana A, et al. Promoting healthy lifestyle habits among participants in cancer screening programs: results of the randomized controlled Sti.Vi study. J Public Health Res. 2022;11.","DOI":"10.1177\/22799036221106542"},{"key":"17293_CR39","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.1158\/1055-9965.EPI-06-0556","volume":"15","author":"S Vaccarella","year":"2006","unstructured":"Vaccarella S, Herrero R, Dai M, Snijders PJF, Meijer CJLM, Thomas JO, et al. Reproductive factors, oral contraceptive use, and human papillomavirus infection: pooled analysis of the IARC HPV prevalence surveys. Cancer Epidemiol Biomark Prev. 2006;15:2148\u201353.","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"17293_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12884-022-04843-4","volume":"22","author":"VYF Maas","year":"2022","unstructured":"Maas VYF, Poels M, de Kievit MH, Hartog AP, Franx A, Koster MPH. Planning is not equivalent to preparing, how Dutch women perceive their pregnancy planning in relation to preconceptional lifestyle behaviour change - a cross-sectional study. BMC Pregnancy Childbirth. 2022;22:1\u201312.","journal-title":"BMC Pregnancy Childbirth"},{"key":"17293_CR41","first-page":"19","volume":"29","author":"M Casparie","year":"2007","unstructured":"Casparie M, Tiebosch ATMG, Burger G, Blauwgeers H, Van De Pol A, Van Krieken JHJM, et al. Pathology Databanking and Biobanking in The Netherlands, a Central Role for PALGA, the Nationwide Histopathology and Cytopathology Data Network and Archive. Cell Oncol. 2007;29:19.","journal-title":"Cell Oncol"},{"key":"17293_CR42","doi-asserted-by":"publisher","first-page":"966155","DOI":"10.3389\/fpubh.2022.966155","volume":"10","author":"EE Schermer","year":"2022","unstructured":"Schermer EE, Engelfriet PM, Blokstra A, Verschuren WMM, Picavet HSJ. Healthy lifestyle over the life course: population trends and individual changes over 30 years of the Doetinchem Cohort Study. Front Public Health. 2022;10.","journal-title":"Front Public Health"},{"key":"17293_CR43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2458-12-715","volume":"12","author":"SH Van Oostrom","year":"2012","unstructured":"Van Oostrom SH, Picavet HSJ, Van Gelder BM, Lemmens LC, Hoeymans N, Van Dijk CE, et al. Multimorbidity and comorbidity in the Dutch population-data from general practices. BMC Public Health. 2012;12:1\u20139.","journal-title":"BMC Public Health"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-023-17293-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-023-17293-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-023-17293-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,30]],"date-time":"2023-11-30T11:03:28Z","timestamp":1701342208000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-023-17293-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,30]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["17293"],"URL":"https:\/\/doi.org\/10.1186\/s12889-023-17293-0","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,30]]},"assertion":[{"value":"4 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all participants. The Lifelines study complies with the principles of the Declaration of Helsinki and has received approval from the Medical Ethics Committee of the University Medical Center Groningen, the Netherlands (no. 2007\/152).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Bert van der Vegt reports scientific advisory board\/consultancy (on request): Visiopharm, Philips, MSD\/Merck, Daiichi-Sankyo\/AstraZeneca; Speaker\u2019s fee from Visiopharm, Diaceutics, MSD\/Merck. All honoraria to UMCG. All unrelated to the current manuscript.Ed Schuuring reports lectures for Bio-Rad, SeraCare, Novartis, Roche, Biocartis, Illumina, Lilly, Janssen Cilag, Pfizer, AstraZeneca and Agena Bioscience; consultant in advisory boards for MSD\/Merck, GSK, AstraZeneca, Astellas Pharma, Roche, Pfizer, Novartis, Bayer, BMS, Lilly, Amgen, Biocartis, Illumina, Agena Bioscience, Janssen Cilag (Johnson & Johnson), Diaceutics, CC Diagnostics; and received research grants from Pfizer, Biocartis, Invitae-ArcherDX, AstraZeneca, Agena Bioscience, BMS, Bio-Rad, Roche, Boehringer Ingelheim (honoraria paid to UMCG account). All unrelated to the current manuscript.The rest of the authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2376"}}